Approach To Patient
Acute Upper Gastrointestinal Bleeding in Children - Approach to the Patient
Editors: Dawn Ebach MD; Allen Shaughnessy PharmD, M Med Ed, FCCP; Scott A. Barron MD, FAAP
Background Information
Description
Also Called
- acute UGIB
- acute upper gastrointestinal hemorrhage
Classifications
- classification of upper gastrointestinal bleeding by etiology
- nonvariceal bleeding
- reported to be most common type in children
- common causes include
- Mallory-Weiss tears
- erosive esophagitis
- peptic ulcers
- emetogenic gastropathy (prolapse gastropathy) (J Pediatr Gastroenterol Nutr 2000 Apr;30(4):458)
- less common causes
- Dieulafoy lesions
- arteriovenous malformations
- telangiectasias
- variceal bleeding
- commonly associated with cirrhosis and chronic liver disease leading to portal hypertension and eventual esophageal varices
- may also be associated with noncirrhotic liver fibrosis or portal venous malformation/cavernous transformation (Expert Rev Gastroenterol Hepatol 2015 May;9(5):575)
- nonvariceal bleeding
Incidence and Prevalence
- reported to account for ≤ 20% of all gastrointestinal bleeds in children
- STUDY SUMMARYannual incidence of upper gastrointestinal bleeding in children 22.2 cases per 10,000 hospital discharges in the United StatesCOHORT STUDY: Curr Med Res Opin 2014 Jun;30(6):1065
- STUDY SUMMARY20% prevalence of upper gastrointestinal bleeding among children visiting emergency departments in the United StatesCOHORT STUDY: Curr Med Res Opin 2015 Feb;31(2):347
- incidence in France reported to be 1-2 cases per 10,000 children
- incidence of variceal bleeding due to portal hypertension reported to be 1 per 200,000 children in Canada
- STUDY SUMMARYannual incidence of peptic ulcer bleeding 0.5-4.4 cases per 100,000 children in United StatesCOHORT STUDY: J Pediatr Gastroenterol Nutr 2012 Jun;54(6):733
Risk Factors
- risk factors for severe upper gastrointestinal bleeding include
- use of nonsteroidal anti-inflammatory drugs (NSAIDs)
- Helicobacter pylori infection
- other risk factors include
- bleeding disorders such as
- peptic ulcer disease
- portal hypertension or varices caused by
- biliary atresia
- portal vein thrombosis
- primary sclerosing cholangitis
- autoimmune hepatitis
- Budd-Chiari syndrome
- cystic fibrosis
- congenital hepatic fibrosis (GeneReviews 2014)
- stress in critical care settings (particularly if not having prophylactic treatment),
- comorbid conditions such as
- coagulopathy
- pneumonia
- multiple traumas
- shock
- organ failure or mechanical ventilation requiring high-pressure ventilator setting
- operative procedures lasting > 3 hours
- comorbid conditions such as
- increased risk of gastric or duodenal ulcers in children with
- burns
- severe or critical illness-associated stress
- increased intracranial pressure
Published by EBSCO Information Services. Copyright © 2025, EBSCO Information Services. All rights reserved. No part of this may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission.
EBSCO Information Services accepts no liability for advice or information given herein or errors/omissions in the text. It is merely intended as a general informational overview of the subject for the healthcare professional.
DynaMed Levels of Evidence
Quickly find and determine the quality of the evidence.
DynaMed provides easy-to-interpret Level of Evidence labels so users can quickly find and determine the quality of the best available evidence. Evidence may be labeled in one of three levels:
1Level 1 (likely reliable) Evidence
2Level 2 (mid-level) Evidence
3Level 3 (lacking direct) Evidence
Grades of Recommendation
Guideline producers are now frequently using classification approaches for their evidence and recommendations, and these classifications are recognized and requested by guideline users. When summarizing guideline recommendations for DynaMed users, the DynaMed Editors are using the guideline-specific classifications and providing guideline classification approach when this is done.
Download the full version of Levels of Evidence